Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("FILLER, Scott G")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 38

  • Page / 2
Export

Selection :

  • and

Candida-host cell receptor-ligand interactionsFILLER, Scott G.Current opinion in microbiology. 2006, Vol 9, Num 4, pp 333-339, issn 1369-5274, 7 p.Article

Interactions of Aspergillus fumigatus with endothelial cells : Internalization, injury, and stimulation of tissue factor activityLOPES BEZERRA, Leila M; FILLER, Scott G.Blood. 2004, Vol 103, Num 6, pp 2143-2149, issn 0006-4971, 7 p.Article

Current treatment strategies for disseminated candidiasisSPELLBERG, Brad J; FILLER, Scott G; EDWARDS, John E et al.Clinical infectious diseases. 2006, Vol 42, Num 2, pp 244-251, issn 1058-4838, 8 p.Article

Mice with disseminated candidiasis die of progressive sepsisSPELLBERG, Brad; IBRAHIM, Ashraf S; EDWARDS, John E et al.The Journal of infectious diseases. 2005, Vol 192, Num 2, pp 336-343, issn 0022-1899, 8 p.Article

New model of oropharyngeal candidiasis in miceKAMAI, Yasuki; KUBOTA, Mikie; KAMAI, Yoko et al.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 11, pp 3195-3197, issn 0066-4804Article

In vivo and ex vivo comparative transcriptional profiling of invasive and non-invasive Candida albicans isolates identifies genes associated with tissue invasionTHEWES, Sascha; KRETSCHMAR, Marianne; PARK, Hyunsook et al.Molecular microbiology (Print). 2007, Vol 63, Num 6, pp 1606-1628, issn 0950-382X, 23 p.Article

Contribution of Candida albicans ALS1 to the pathogenesis of experimental oropharyngeal candidiasisKAMAI, Yasuki; KUBOTA, Mikie; KAMAI, Yoko et al.Infection and immunity. 2002, Vol 70, Num 9, pp 5256-5258, issn 0019-9567, 3 p.Article

Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunityIBRAHIM, Ashraf S; SPELLBERG, Brad J; AVENISSIAN, Valentina et al.Infection and immunity. 2005, Vol 73, Num 2, pp 999-1005, issn 0019-9567, 7 p.Article

Guidelines for treatment of candidiasisPAPPAS, Peter G; REX, John H; SOBEL, Jack D et al.Clinical infectious diseases. 2004, Vol 38, Num 2, pp 161-189, issn 1058-4838, 29 p.Article

Efficacy of ambruticin analogs in a murine model of invasive pulmonary aspergillosisCHIANG, Lisa Y; EJZYKOWICZ, Daniele E; TIAN, Zong-Qiang et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 10, pp 3464-3466, issn 0066-4804, 3 p.Article

Tumor necrosis factor inhibition and invasive fungal infectionsFILLER, Scott G; YEAMAN, Michael R; SHEPPARD, Donald C et al.Clinical infectious diseases. 2005, Vol 41, pp S208-S212, issn 1058-4838, SUP3Article

Role of Trehalose Biosynthesis in Aspergillus fumigatus Development, Stress Response, and VirulenceAL-BADER, Nadia; VANIER, Ghyslaine; HONG LIU et al.Infection and immunity. 2010, Vol 78, Num 7, pp 3007-3018, issn 0019-9567, 12 p.Article

Transcriptome Profile of the Vascular Endothelial Cell Response to Candida albicansBARKER, Katherine S; PARK, Hyunsook; PHAN, Quynh T et al.The Journal of infectious diseases. 2008, Vol 198, Num 2, pp 193-202, issn 0022-1899, 10 p.Article

The anti-Candida albicans vaccine composed of the recombinant N terminus of Als1p reduces fungal burden and improves survival in both immunocompetent and immunocompromised miceSPELLBERG, Brad J; IBRAHIM, Ashraf S; AVENISSIAN, Valentina et al.Infection and immunity. 2005, Vol 73, Num 9, pp 6191-6193, issn 0019-9567, 3 p.Article

Novel inhalational murine model of invasive pulmonary aspergillosisSHEPPARD, Donald C; RIEG, Gunter; CHIANG, Lisa Y et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 5, pp 1908-1911, issn 0066-4804, 4 p.Article

Pharmacokinetics of Posaconazole Within Epithelial Cells and Fungi: Insights Into Potential Mechanisms of Action During Treatment and ProphylaxisCAMPOLI, Paolo; PERLIN, David S; KRISTOF, Arnold S et al.The Journal of infectious diseases. 2013, Vol 208, Num 10, pp 1717-1728, issn 0022-1899, 12 p.Article

Clinical Practice Guidelines for the Management of Candidiasis : 2009 Update by the Infectious Diseases Society of AmericaPAPPAS, Peter G; KAUFFMAN, Carol A; REBOLI, Annette C et al.Clinical infectious diseases. 2009, Vol 48, Num 5, pp 503-535, issn 1058-4838, 33 p.Article

Combination Polyene-Caspofungin Treatment of Rhino-Orbital-Cerebral Mucormycosis. CommentaryREED, Caitlin; BRYANT, Richard; IBRAHIM, Ashraf S et al.Clinical infectious diseases. 2008, Vol 47, Num 3, pp 364-374, issn 1058-4838, 11 p.Article

The Antifungal Vaccine Derived from the Recombinant N Terminus of Als3p Protects Mice against the Bacterium Staphylococcus aureusSPELLBERG, Brad; IBRAHIM, Ashraf S; EDWARDS, John E et al.Infection and immunity. 2008, Vol 76, Num 10, pp 4574-4580, issn 0019-9567, 7 p.Article

A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis : AIDS clinical trials group study 323/mycoses study group study 40. CommentaryGOLDMAN, Mitchell; CLOUD, Gretchen A; STEIN, David K et al.Clinical infectious diseases. 2005, Vol 41, Num 10, pp 1473-1482, issn 1058-4838, 10 p.Article

Genetic basis for differential activities of fluconazole and voriconazole against Candida kruseiFUKUOKA, Takashi; JOHNSTON, Douglas A; WINSLOW, Carol A et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 4, pp 1213-1219, issn 0066-4804, 7 p.Article

Parenchymal organ, and not splenic, immunity correlates with host survival during disseminated candidiasisSPELLBERG, Brad; JOHNSTON, Douglas; QUYNH TRANG PHAN et al.Infection and immunity. 2003, Vol 71, Num 10, pp 5756-5764, issn 0019-9567, 9 p.Article

A Phase II Randomized Trial of Amphotericin B Alone or Combined with Fluconazole in the Treatment of HIV-Associated Cryptococcal MeningitisPAPPAS, Peter G; CHETCHOTISAKD, Ploenchan; KENDRICK, Amy S et al.Clinical infectious diseases. 2009, Vol 48, Num 12, pp 1775-1783, issn 1058-4838, 9 p.Article

The Aspergillus fumigatus transcription factor Ace2 governs pigment production, conidiation and virulenceEJZYKOWICZ, Daniele E; CUNHA, Marcel M; ROZENTAL, Sonia et al.Molecular microbiology (Print). 2009, Vol 72, Num 1, pp 155-169, issn 0950-382X, 15 p.Article

Gliotoxin Production in Aspergillus fumigatus Contributes to Host-Specific Differences in VirulenceSPIKES, Sara; RAN XU; NGUYEN, C. Kim et al.The Journal of infectious diseases. 2008, Vol 197, Num 3, pp 479-486, issn 0022-1899, 8 p.Article

  • Page / 2